Publication: Cytotechnologist-attended on-site evaluation of adequacy for metastatic disease involving bone and soft tissue
Issued Date
2013-01-01
Resource Type
ISSN
19382650
00015547
00015547
Other identifier(s)
2-s2.0-84889576155
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Acta Cytologica. Vol.57, No.6 (2013), 550-556
Suggested Citation
Matthew T. Olson, Anna Novak, John Kirby, Hinna Shahid, Thiraphon Boonyaarunnate, Syed Z. Ali Cytotechnologist-attended on-site evaluation of adequacy for metastatic disease involving bone and soft tissue. Acta Cytologica. Vol.57, No.6 (2013), 550-556. doi:10.1159/000354079 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/32638
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cytotechnologist-attended on-site evaluation of adequacy for metastatic disease involving bone and soft tissue
Other Contributor(s)
Abstract
Introduction: Image-guided fine needle aspiration (FNA) of the musculoskeletal system is expensive to perform and repeat, so on-site evaluation of adequacy (OSEA) is increasingly used to ensure an optimal sample. Metastatic disease to the musculoskeletal system is not uncommon and often requires OSEA when sampled. At large academic centers, cytotechnologists have filled the increased demand for OSEA. However, the performance of cytotechnologists has not been compared with that of cytopathologists for OSEA in FNA of metastatic disease involving bone and soft tissue. Methods: We retrospectively analyzed 10 years of data in which both cytotechnologists and cytopathologists performed OSEA for 1,995 FNAs of bone and soft tissue sites in which metastatic malignancy was suspected or found. We calculated adequacy and accuracy statistics in conjunction with other variables including imaging modality, biopsy site, accompanying core biopsy, tissue type, final diagnosis, and number of smears. Results: A total of 1,995 aspirates of metastatic disease carcinoma, melanoma or lymphoma to bone or soft tissue had OSEA performed by cytotechnologists (681, 33.7%) or cytopathologists (1,314, 66.3%). The adequacy downgrade rate was statistically equivalent (4.1 vs. 3.6%; p = 0.64). Conclusion: Cytotechnologists and cytopathologists perform with reasonable equivalence at OSEA of aspirates from metastatic carcinoma, melanoma or lymphoma involving bone or soft tissue. © 2013 S. Karger AG, Basel.